Tokyo firm targets blood tests for Alzheimer's in wake of th

Fujirebio Holding is boosting its lineup of reagents used to detect Alzheimer’s biomarkers in blood tests.

Related Keywords

Tokyo , Japan , United States , , Fujirebio Holding , Hu Group Holdings , Fujirebio Chief Executive Officer Goki , Pharmaceuticals , Dementia , Alzheimer 039 S , Fujirebio ,